Estuary Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History
Estuary Capital Management LP
- $246 Billion
- Q1 2024
A detailed history of Estuary Capital Management LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Estuary Capital Management LP holds 1,611,137 shares of DAWN stock, worth $21.4 Million. This represents 10.81% of its overall portfolio holdings.
Number of Shares
1,611,137
Previous 882,897
82.48%
Holding current value
$21.4 Million
Previous $12.9 Billion
106.48%
% of portfolio
10.81%
Previous 7.8%
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$85.3 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$66.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$63.4 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$50.5 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$38.4 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $975M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...